Literature DB >> 2902292

Danger of MAOI therapy after fluoxetine withdrawal.

H Sternbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902292     DOI: 10.1016/s0140-6736(88)92812-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Depression and myocardial infarction. Implications for medical prognosis and options for treatment.

Authors:  T J Cleophas
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly.

Authors:  Brian Draper; Karen Berman
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Authors:  Lois Jessen; Lawrence J Kovalick; Albert J Azzaro
Journal:  P T       Date:  2008-04

Review 4.  Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice.

Authors:  J R Rosenbaum
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 5.  Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Authors:  P B Mitchell
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

6.  Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.

Authors:  Z Speiser; T Fine; L Litinetsky; S Eliash; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

Review 7.  Treatment considerations for the depressed geriatric medical patient.

Authors:  H G Koenig
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 8.  Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease.

Authors:  P Chrisp; G J Mammen; E M Sorkin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 9.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 10.  Comparative tolerability profiles of the newer versus older antidepressants.

Authors:  M V Rudorfer; H K Manji; W Z Potter
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.